KITE

KITE PHARMA, INC. (KITE)

Kite Pharma, Inc.

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KITE

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
10/13/2017	5:05PM	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:KITE	Kite Pharma, Inc.
10/05/2017	3:44PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KITE	Kite Pharma, Inc.
10/03/2017	5:12PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KITE	Kite Pharma, Inc.
10/03/2017	5:07PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KITE	Kite Pharma, Inc.
10/03/2017	5:02PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KITE	Kite Pharma, Inc.
10/03/2017	4:57PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KITE	Kite Pharma, Inc.
10/03/2017	4:56PM	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:KITE	Kite Pharma, Inc.
10/03/2017	4:44PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KITE	Kite Pharma, Inc.
10/03/2017	9:03AM	Edgar (US Regulatory)	(25-NSE)	NASDAQ:KITE	Kite Pharma, Inc.
10/03/2017	8:46AM	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:KITE	Kite Pharma, Inc.
10/03/2017	8:45AM	Business Wire	Gilead Sciences Completes Acquisition of Kite Pharma, Inc.	NASDAQ:KITE	Kite Pharma, Inc.
10/03/2017	8:17AM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:KITE	Kite Pharma, Inc.
10/03/2017	8:00AM	Business Wire	Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.	NASDAQ:KITE	Kite Pharma, Inc.
09/26/2017	8:54AM	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:KITE	Kite Pharma, Inc.
09/26/2017	8:40AM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:KITE	Kite Pharma, Inc.
09/26/2017	8:30AM	Business Wire	Gilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting Period	NASDAQ:KITE	Kite Pharma, Inc.
09/25/2017	5:17PM	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:KITE	Kite Pharma, Inc.
09/25/2017	5:13PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KITE	Kite Pharma, Inc.
09/25/2017	4:31PM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:KITE	Kite Pharma, Inc.
09/22/2017	4:18PM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:KITE	Kite Pharma, Inc.
09/18/2017	5:29PM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:KITE	Kite Pharma, Inc.
09/15/2017	4:52PM	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:KITE	Kite Pharma, Inc.
09/08/2017	5:30PM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:KITE	Kite Pharma, Inc.
09/08/2017	5:24PM	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:KITE	Kite Pharma, Inc.
09/08/2017	1:37PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KITE	Kite Pharma, Inc.
09/07/2017	4:12PM	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:KITE	Kite Pharma, Inc.
09/05/2017	4:13PM	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:KITE	Kite Pharma, Inc.
09/05/2017	4:09PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KITE	Kite Pharma, Inc.
09/05/2017	12:24PM	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:KITE	Kite Pharma, Inc.
09/01/2017	5:28PM	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:KITE	Kite Pharma, Inc.